ANTIVIRAL AGENTS .2. STRUCTURE-ACTIVITY RELATIONSHIPS OF COMPOUNDS RELATED TO 1-ADAMANTANAMINE
ANTIVIRAL AGENTS .2. STRUCTURE-ACTIVITY RELATIONSHIPS OF COMPOUNDS RELATED TO 1-ADAMANTANAMINE
复制标题
DOI:
10.1021/jm00288a019
复制
发表时间:
1971-01-01
影响因子:
7.3
通讯作者:
WATTS, JC
中科院分区:
文献类型:
--
作者:
ALDRICH, PE;HERMANN, EC;WATTS, JC
(6) W. L. Wingfield, D. Pollack, and RR Grunert, N. Engl. J. Med., 281, 579 (1969). and with rimantadine· HCl6 (a-methyl-l-adamantane-methylamine· HCl, 58) in patients with natu-rally occurring influenza A2 respiratory illness. Inhibi-tion of rubella, 7 Rous sarcoma, 8· 9 and Esh sarcoma viruses has also been reported. Amantadine· HCl more recently has been demonstrated to benefit pa-tients suffering from Parkinson’s disease. 10 Meanwhile, others11 have disclosed results from drugs that include the adamantane moiety. No systematic study of the effect of structural varia-tions of 1-adamantanamine upon antiviral activity has (7)(a) KW Cochran and HF Maassab, Fed. Proc., Fed. Amer. Soc. Exp. Biol., 23, 387 (1964);(b) A. Tsunoda, HF Maassab, KW Cochran, and W. E. Eveland, Antimicrob. Ag. Chemother., 553 (1965).(8) N. Oker-Blom and AL Anderson, Eur. J. Cancer, 2, 9 (1966).(9) A. M. Wallbank, RE Matter, and NG Klinikowski, Science, 152, 1760 (1966).